Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 12374669

Approval summary: imatinib mesylate in the treatment of metastatic and/or unresectable malignant gastrointestinal stromal tumors.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Clin Cancer Res
Publication date
2002 Oct
First author
Dagher R

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Dagher R
      type
      Author
    2. name
      Cohen M
      type
      Author
    3. name
      Williams G
      type
      Author
    4. name
      Rothmann M
      type
      Author
    5. name
      Gobburu J
      type
      Author
    6. name
      Robbie G
      type
      Author
    7. name
      Rahman A
      type
      Author
    8. name
      Chen G
      type
      Author
    9. name
      Staten A
      type
      Author
    10. name
      Griebel D
      type
      Author
    11. name
      Pazdur R
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Dagher R
      type
      Author
    2. name
      Cohen M
      type
      Author
    3. name
      Williams G
      type
      Author
    4. name
      Rothmann M
      type
      Author
    5. name
      Gobburu J
      type
      Author
    6. name
      Robbie G
      type
      Author
    7. name
      Rahman A
      type
      Author
    8. name
      Chen G
      type
      Author
    9. name
      Staten A
      type
      Author
    10. name
      Griebel D
      type
      Author
    11. name
      Pazdur R
      type
      Author
    bibliography ids
    1. nci-bib-9cd1e2dec96c5b0b7312ddc5
    book metadata
    content sha256
    ad6c34b6afc97900edc2f0206995e0c0e16f4994fa4ee54115d5ec9962c5a402
    document type
    citation
    dois
      electronic publication date
      display
      Source null
      precision
      missing
      year
      Source null
      evidence scope
      bibliographic_metadata_only
      id
      pubmed:12374669
      immutable id
      pubmed:12374669@ad6c34b6afc97900edc2f0206995e0c0e16f4994fa4ee54115d5ec9962c5a402
      journal
      abbreviation
      Clin Cancer Res
      issn electronic
      Source null
      issn print
      1078-0432
      issue
      10
      name
      Clinical cancer research : an official journal of the American Association for Cancer Research
      nlm unique id
      9502500
      pages
      3034-8
      volume
      8
      languages
      1. eng
      notices
      absence is not clearance
      true
      has correction metadata
      false
      has expression of concern metadata
      false
      has retraction in link
      false
      pubmed marks article retracted
      false
      pubmed marks retraction notice
      false
      relationships
        outcomes validated
        false
        pmid
        12374669
        provenance
        batch id
        ced7794d3512d3f45188
        provider
        NCBI PubMed ESummary
        record sha256
        81cea25978899ac6733bf29a05a8eb4a65296e5cb7242cc390dcb0feaa258a4d
        response sha256
        782bfef1f051086807ee9551561575ae64b9ca1f941a87d5259ff83e5424435e
        retrieved at
        2026-09-09T23:45:46.208577+00:00
        publication date
        display
        2002 Oct
        precision
        month
        year
        2002
        publication types
        1. Clinical Trial
        2. Clinical Trial, Phase II
        3. Journal Article
        4. Multicenter Study
        record status
        PubMed - indexed for MEDLINE
        schema version
        1.0
        source url
        https://pubmed.ncbi.nlm.nih.gov/12374669/
        title
        Approval summary: imatinib mesylate in the treatment of metastatic and/or unresectable malignant gastrointestinal stromal tumors.

        Preserved source evidence · Not medical advice